Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
150
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2015
0Study Completion Date
2015
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Rifampin0
Ataluren0
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
A Phase I Study Assessing the Effects of Rifampin on the Pharmacokinetics of Ataluren in Healthy Subjects0
Last Updated
December 22, 2017
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
This will be a single centre, Phase I, open-label, one cohort, one dose level, fixed-sequence, drug interaction study in healthy volunteers. The objective of this study is to determine the effects of rifampin on the pharmacokinetics of ataluren under fasting conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
